[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Srivastava et al., 2023 - Google Patents

Japanese encephalitis virus: an update on the potential antivirals and vaccines

Srivastava et al., 2023

View HTML
Document ID
14405009329431173793
Author
Srivastava K
Jeswani V
Pal N
Bohra B
Vishwakarma V
Bapat A
Patnaik Y
Khanna N
Shukla R
Publication year
Publication venue
Vaccines

External Links

Snippet

Japanese encephalitis virus (JEV) is the causal agent behind Japanese encephalitis (JE), a potentially severe brain infection that spreads through mosquito bites. JE is predominant over the Asia-Pacific Region and has the potential to spread globally with a higher rate of …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense
    • C12N2770/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense ssRNA Viruses positive-sense
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens

Similar Documents

Publication Publication Date Title
Srivastava et al. Japanese encephalitis virus: an update on the potential antivirals and vaccines
Nanaware et al. Dengue virus infection: a tale of viral exploitations and host responses
Nelemans et al. Viral innate immune evasion and the pathogenesis of emerging RNA virus infections
Obi et al. Current trends and limitations in dengue antiviral research
Norshidah et al. Updates on dengue vaccine and antiviral: where are we heading?
Bai et al. Current understanding of West Nile virus clinical manifestations, immune responses, neuroinvasion, and immunotherapeutic implications
Zhao et al. Flavivirus: from structure to therapeutics development
Baz et al. Antiviral agents in development for Zika virus infections
Lee et al. Molecular mechanisms of antiviral agents against dengue virus
Oliveira et al. Potential antivirals: natural products targeting replication enzymes of dengue and chikungunya viruses
Low et al. SARS-CoV-2 non-structural proteins and their roles in host immune evasion
Morrison et al. Innate immunity evasion by Dengue virus
Panda et al. In vitro antiviral activity of α-mangostin against dengue virus serotype-2 (DENV-2)
Cho et al. Immune responses to West Nile virus infection in the central nervous system
Lee et al. Advances in Zika virus–host cell interaction: Current knowledge and future perspectives
Tremblay et al. The interplay between dengue virus and the human innate immune system: a game of hide and seek
Thurmond et al. Suppression of type I interferon signaling by flavivirus NS5
Coldbeck-Shackley et al. The molecular interactions of ZIKV and DENV with the type-I IFN response
Da Silva et al. A review of the ongoing research on Zika virus treatment
Quicke et al. The innate immune playbook for restricting West Nile virus infection
Fernandes et al. Reporter replicons for antiviral drug discovery against positive single-stranded RNA viruses
Ahammad et al. Contemporary strategies and current trends in designing antiviral drugs against dengue fever via targeting host-based approaches
Latanova et al. Flaviviridae nonstructural proteins: the role in molecular mechanisms of triggering inflammation
Siri et al. Autophagy, unfolded protein response, and neuropilin-1 cross-talk in SARS-CoV-2 infection: What can be learned from other coronaviruses
Mammari et al. Plant-derived antimicrobial peptides as potential antiviral agents in systemic viral infections